Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Myovant Sciences Ltd (NYSE: MYOV)

$12.23 USD $0.06 (0.49%)
Last Price $12.23
Net Change $0.06 (0.49%)
Bid $0
Ask Price $0
Open Price $12.17
Previous Close Price $12.17
High Price $12.44
Low Price $11.87
Number of Trades 90
Volume 19,700
Fifty Two Week High $15.5 (2016-10-27)
Fifty Two Week Low $10.25 (2016-12-08)
Average Daily Volume 68,449
Share Outstanding 60,260 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $39.86
Recent Earnings $
Annual EPS $-0.15
Last Quarter EPS $
Market Capitalization $0.74B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 60,260
Inst. Shareholder % 82.86%
Annual Net Income $0B
TTM Net Profit Margin $100.62
1-Year Return -7.77%
3-Year Return -7.77%
5-Year Return -7.77%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 39.860001%
Dividends per Share $
Stock Split Ratio
Beta
Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders, including advanced prostate cancer. The company's product candidate consists of relugolix which are in clinical trial, an oral once-daily small molecule that acts as a gonadotropin-releasing hormone receptor antagonist. Myovant Sciences Ltd. is based in Hamilton, Bermuda.

MYOV News & Stock Updates